Revenue: The sum of all revenue fields included for a company's operating activities.
Xenetic Biosciences, Inc. (XBIO) had Revenue of $0.59M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$0.59M |
$-0.69M |
|
-- |
|
$0.59M |
|
$1.31M |
|
$-0.72M |
|
$0.04M |
|
$-0.69M |
|
$-0.69M |
|
$-0.69M |
|
$-0.69M |
|
$-0.69M |
|
$-0.69M |
|
$-0.72M |
|
$-0.72M |
|
1.54M |
|
1.54M |
|
$-0.45 |
|
$-0.45 |
|
| Balance Sheet Financials | |
$5.35M |
|
-- |
|
-- |
|
$5.35M |
|
$0.90M |
|
-- |
|
-- |
|
$0.90M |
|
$4.45M |
|
$4.45M |
|
$4.45M |
|
1.54M |
|
| Cash Flow Statement Financials | |
$-1.39M |
|
-- |
|
-- |
|
$6.17M |
|
$4.78M |
|
$-1.39M |
|
$0.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.93 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-122.80% |
|
-122.80% |
|
-- |
|
-116.75% |
|
-116.75% |
|
$-1.39M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
-- |
|
-- |
|
-- |
|
-15.48% |
|
-15.48% |
|
-12.86% |
|
-15.48% |
|
$2.89 |
|
$-0.90 |
|
$-0.90 |
|